Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Autonomic Dysregulation in Multiple Sclerosis.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
[Symptoms and clinical manifestations in neuromyelitis optica].
Country break-out session highlights.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
Special considerations when coding for patients with multiple sclerosis.
Developing and implementing lifestyle management programs© with people with multiple sclerosis.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
Neurological disorders: Differential methylation in multiple sclerosis.
Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes.
Unmasking and provoking severe disease activity in a patient with NMO spectrum disorder.
Natalizumab to fingolimod: Questions answered, unanswered, and unasked.
Regenerative Medicines for Remyelination: From Aspiration to Reality.

Pages